{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:03:08Z","timestamp":1789603388916,"version":"build-2803163510"},"reference-count":160,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016019","name":"Federal State of Thuringia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.apsb.2026.06.056","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:44:24Z","timestamp":1782949464000},"page":"6099-6128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tocotrienol metabolites redirect lipid mediator production in innate immune cells towards inflammation resolution"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8236-3897","authenticated-orcid":false,"given":"Stephan","family":"Permann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Alsabil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0298-5136","authenticated-orcid":false,"given":"Markus","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0385-7216","authenticated-orcid":false,"given":"Lorenz","family":"Waltl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Viault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6350-5191","authenticated-orcid":false,"given":"Danilo","family":"D\u2019Avino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Perkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7860-7144","authenticated-orcid":false,"given":"Anita","family":"Siller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6438-9137","authenticated-orcid":false,"given":"Sara","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Schennach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"S\u00e9raphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveigh C.","family":"Koeberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8364-4236","authenticated-orcid":false,"given":"Paul M.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorentina","family":"Roviezzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-2556","authenticated-orcid":false,"given":"Pascal","family":"Richomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1894-8911","authenticated-orcid":false,"given":"Jean-Jacques","family":"Helesbeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6269-5088","authenticated-orcid":false,"given":"Andreas","family":"Koeberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.06.056_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100894","article-title":"The atlas of inflammation resolution (AIR)","volume":"74","author":"Serhan","year":"2020","journal-title":"Mol Aspect Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107879","article-title":"Resolution of inflammation: an organizing principle in biology and medicine","volume":"227","author":"Panigrahy","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.056_bib4","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.056_bib5","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.056_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.08.001","article-title":"Prostaglandins in asthma and allergic diseases","volume":"193","author":"Peebles","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib8","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.7150\/thno.63396","article-title":"Role of prostaglandin E2 in tissue repair and regeneration","volume":"11","author":"Cheng","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.06.056_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.06.022","article-title":"Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders","volume":"98","author":"Koeberle","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib10","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.biotechadv.2018.02.010","article-title":"Natural products as inhibitors of prostaglandin E(2) and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis","volume":"36","author":"Koeberle","year":"2018","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.apsb.2026.06.056_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.06.056_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.06.056_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41467-017-02538-5","article-title":"Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity","volume":"9","author":"Werz","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.056_bib14","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1111\/febs.16266","article-title":"Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections","volume":"289","author":"Jordan","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2026.06.056_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.056_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106726","article-title":"Formation of lipoxins and resolvins in human leukocytes","volume":"166","author":"Kahnt","year":"2023","journal-title":"Prostag Other Lipid Mediat"},{"key":"10.1016\/j.apsb.2026.06.056_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108460","article-title":"Is there a role for specialized pro-resolving mediators in pulmonary fibrosis?","volume":"247","author":"Thatcher","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.838782","article-title":"Formation, signaling and occurrence of specialized pro-resolving lipid mediators-what is the evidence so far?","volume":"13","author":"Schebb","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","article-title":"Targeting inflammation in the treatment of type 2 diabetes: time to start","volume":"13","author":"Donath","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.06.056_bib20","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1172\/JCI90609","article-title":"CNS inflammation and neurodegeneration","volume":"127","author":"Chitnis","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.056_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.06.056_bib22","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: a new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.06.056_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","article-title":"Inflammation resolution: implications for atherosclerosis","volume":"130","author":"Doran","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-pharmtox-051921-084047","article-title":"Specialized pro-resolving mediators as resolution pharmacology for the control of pain and itch","volume":"63","author":"Ji","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.056_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-pharmtox-051821-042743","article-title":"Resolution pharmacology: focus on pro-resolving annexin A1 and lipid mediators for therapeutic innovation in inflammation","volume":"63","author":"Perretti","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.056_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-pharmtox-051921-085407","article-title":"Lipoxin mimetics and the resolution of inflammation","volume":"63","author":"Godson","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.056_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108453","article-title":"Resolution of inflammation in oral diseases","volume":"247","author":"Eltay","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107670","article-title":"Carcinogenesis: failure of resolution of inflammation?","volume":"218","author":"Fishbein","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10555-021-10017-z","article-title":"COVID-19 and cancer: start the resolution","volume":"41","author":"Barksdale","year":"2022","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.apsb.2026.06.056_bib31","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI97945","article-title":"Leukotriene biosynthetic enzymes as therapeutic targets","volume":"128","author":"Haeggstrom","year":"2018","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.056_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10555-023-10091-5","article-title":"Resolution medicine in cancer, infection, pain and inflammation: are we on track to address the next Pandemic?","volume":"42","author":"Serhan","year":"2023","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.apsb.2026.06.056_bib33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2147\/JIR.S345510","article-title":"Shifting the biosynthesis of leukotrienes toward specialized pro-resolving mediators by the 5-lipoxygenase-activating protein (FLAP) antagonist BRP-201","volume":"15","author":"Kretzer","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib34","article-title":"Allosteric activation of 15-lipoxygenase-1 by boswellic acid induces the lipid mediator class switch to promote resolution of inflammation","volume":"10","author":"Borner","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2026.06.056_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114825","article-title":"Natural chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages","volume":"195","author":"Kretzer","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105556","article-title":"Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators","volume":"167","author":"Pace","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib37","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.apsb.2021.04.011","article-title":"From Vietnamese plants to a biflavonoid that relieves inflammation by triggering the lipid mediator class switch to resolution","volume":"11","author":"Van Anh","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.056_bib38","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1096\/fj.201802509R","article-title":"Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome","volume":"33","author":"Werner","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.06.056_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115202","article-title":"Rotational constriction of curcuminoids impacts 5-lipoxygenase and mPGES-1 inhibition and evokes a lipid mediator class switch in macrophages","volume":"203","author":"Rao","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ejmech.2018.07.031","article-title":"Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation","volume":"156","author":"Cheung","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3389\/fphar.2019.00797","article-title":"Ginkgolic acid is a multi-target inhibitor of key enzymes in pro-inflammatory lipid mediator biosynthesis","volume":"10","author":"Gerstmeier","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bcp.2019.03.003","article-title":"Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: a promising pharmacological strategy for anti-inflammatory therapy","volume":"165","author":"Gerstmeier","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1254\/jphs.09012FP","article-title":"Oxymetazoline inhibits and resolves inflammatory reactions in human neutrophils","volume":"110","author":"Beck-Speier","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.06.056_bib44","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.chembiol.2023.08.001","article-title":"Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators","volume":"30","author":"Peltner","year":"2023","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.apsb.2026.06.056_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108382","article-title":"The phospholipase A2 superfamily as a central hub of bioactive lipids and beyond","volume":"244","author":"Murakami","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib46","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbalip.2018.08.006","article-title":"Cytosolic phospholipase A2 and lysophospholipid acyltransferases","volume":"1864","author":"Kita","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.apsb.2026.06.056_bib47","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/cr2002992","article-title":"Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis","volume":"111","author":"Smith","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2026.06.056_bib48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-pharmtox-051921-085014","article-title":"Structures of leukotriene biosynthetic enzymes and development of new therapeutics","volume":"63","author":"Haeggstrom","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.056_bib49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.plipres.2013.11.003","article-title":"Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer","volume":"53","author":"Zhang","year":"2014","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.056_bib51","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.tips.2016.08.001","article-title":"Epoxyeicosatrienoic acid as therapy for diabetic and ischemic cardiomyopathy","volume":"37","author":"Romashko","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.06.056_bib52","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","article-title":"Goods and bads of endocannabinoid system as a therapeutic target: lessons learned after 30 years","volume":"75","author":"Maccarrone","year":"2023","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2026.06.056_bib53","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cmet.2021.06.006","article-title":"Sphingolipids in metabolic disease: the good, the bad, and the unknown","volume":"33","author":"Green","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.06.056_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115330","article-title":"Protectins: their biosynthesis, metabolism and structure\u2013functions","volume":"206","author":"Vidar Hansen","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108247","article-title":"Staphylococcus aureus-derived alpha-hemolysin evokes generation of specialized pro-resolving mediators promoting inflammation resolution","volume":"33","author":"Jordan","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.06.056_bib56","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.drudis.2014.08.006","article-title":"Multi-target approach for natural products in inflammation","volume":"19","author":"Koeberle","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2026.06.056_bib57","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fphar.2020.00362","article-title":"Diversity of chromanol and chromenol structures and functions: an emerging class of anti-inflammatory and anti-carcinogenic agents","volume":"11","author":"Wallert","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2016.09.017","article-title":"Vitamin E: emerging aspects and new directions","volume":"102","author":"Galli","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib59","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2015.08.019","article-title":"Human serum determination and in vitro anti-inflammatory activity of the vitamin E metabolite alpha-(13\u2032-hydroxy)-6-hydroxychroman","volume":"89","author":"Ciffolilli","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib60","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1038\/s41467-018-06158-5","article-title":"Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase","volume":"9","author":"Pein","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.056_bib61","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.talanta.2017.04.030","article-title":"Determination of tocopherols and their metabolites by liquid-chromatography coupled with tandem mass spectrometry in human plasma and serum","volume":"170","author":"Giusepponi","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.apsb.2026.06.056_bib62","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1055\/s-0042-108739","article-title":"Semisynthetic and natural garcinoic acid isoforms as new mPGES-1 inhibitors","volume":"82","author":"Alsabil","year":"2016","journal-title":"Planta Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib63","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.2174\/092986709789578178","article-title":"Inhibitors of the microsomal prostaglandin E2 synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)\u2014A critical review","volume":"16","author":"Koeberle","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib64","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/mnfr.201400737","article-title":"\u03b1-Tocopherol long-chain metabolite alpha-13\u2032-COOH affects the inflammatory response of lipopolysaccharide-activated murine RAW264.7 macrophages","volume":"59","author":"Wallert","year":"2015","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib65","doi-asserted-by":"crossref","first-page":"1700562","DOI":"10.1002\/mnfr.201700562","article-title":"Structure\u2013function relationship studies in vitro reveal distinct and specific effects of long-chain metabolites of vitamin E","volume":"61","author":"Schmolz","year":"2017","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.freeradbiomed.2021.11.032","article-title":"The alpha-tocopherol-derived long-chain metabolite alpha-13\u2032-COOH mediates endotoxin tolerance and modulates the inflammatory response via MAPK and NFkappaB pathways","volume":"178","author":"Schubert","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib67","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.chembiol.2021.04.019","article-title":"Endogenous vitamin E metabolites mediate allosteric PPARgamma activation with unprecedented co-regulatory interactions","volume":"28","author":"Willems","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.apsb.2026.06.056_bib68","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1021\/acs.jmedchem.0c00012","article-title":"Garcinoic acid is a natural and selective agonist of pregnane X receptor","volume":"63","author":"Bartolini","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib69","doi-asserted-by":"crossref","first-page":"1600605","DOI":"10.1002\/mnfr.201600605","article-title":"The long chain alpha-tocopherol metabolite alpha-13\u2032-COOH and gamma-tocotrienol induce P-glycoprotein expression and activity by activation of the pregnane X receptor in the intestinal cell line LS 180","volume":"61","author":"Podszun","year":"2017","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib70","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3390\/nano11081939","article-title":"Controlled release of the alpha-tocopherol-derived metabolite alpha-13\u2032-carboxychromanol from bacterial nanocellulose wound cover improves wound healing","volume":"11","author":"Hoff","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2026.06.056_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.freeradbiomed.2013.11.009","article-title":"Long-chain metabolites of \u03b1-tocopherol occur in human serum and inhibit macrophage foam cell formation in vitro","volume":"68","author":"Wallert","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib72","article-title":"The vitamin E long-chain metabolite alpha-13\u2032-COOH affects macrophage foam cell formation via modulation of the lipoprotein lipase system","volume":"1866","author":"Kluge","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.apsb.2026.06.056_bib73","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.3390\/ijms24119229","article-title":"\u03b1-Tocopherol-13\u2032-carboxychromanol induces cell cycle arrest and cell death by inhibiting the SREBP1\u2013SCD1 axis and causing imbalance in lipid desaturation","volume":"24","author":"Liao","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.056_bib74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2025.05.428","article-title":"Garcinoic acid enhances inflammation resolution against colitis by activating Nrf2 dependent efferocytosis","volume":"237","author":"Isot","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib75","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1021\/acs.jmedchem.1c00806","article-title":"Exploration of long-chain vitamin E metabolites for the discovery of a highly potent, orally effective, and metabolically stable 5-LOX inhibitor that limits inflammation","volume":"64","author":"Neukirch","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106250","article-title":"A vitamin E long-chain metabolite and the inspired drug candidate alpha-amplexichromanol relieve asthma features in an experimental model of allergen sensitization","volume":"181","author":"Cerqua","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1021\/acs.jnatprod.8b00517","article-title":"Efficient semi-synthesis of natural delta-(R)-tocotrienols from a renewable vegetal source","volume":"82","author":"Ville","year":"2019","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2026.06.056_bib78","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/np400598y","article-title":"Antiangiogenic tocotrienol derivatives from Garcinia amplexicaulis","volume":"76","author":"Lavaud","year":"2013","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2026.06.056_bib79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.phytochem.2014.10.024","article-title":"A tocotrienol series with an oxidative terminal prenyl unit from Garcinia amplexicaulis","volume":"109","author":"Lavaud","year":"2015","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2026.06.056_bib80","series-title":"Universit\u00e4t Innsbruck, Friedrich-Schiller-Universt\u00e4t Jena, Universit\u00e9 d\u2019Angers. Tocotrienol derivatives, pharmaceutical composition and method of use in 5-lipoxygenase related diseases","author":"Richomme","year":"2017"},{"key":"10.1016\/j.apsb.2026.06.056_bib81","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3390\/plants11162130","article-title":"Phytochemical characterization of Cannabis sativa L. chemotype V reveals three new dihydrophenanthrenoids that favorably reprogram lipid mediator biosynthesis in macrophages","volume":"11","author":"Salamone","year":"2022","journal-title":"Plants"},{"key":"10.1016\/j.apsb.2026.06.056_bib82","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103142","article-title":"Protocol for lipid mediator profiling and phenotyping of human M1- and M2-monocyte-derived macrophages during host-pathogen interactions","volume":"5","author":"Gunther","year":"2024","journal-title":"STAR Protoc"},{"key":"10.1016\/j.apsb.2026.06.056_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106685","article-title":"Novel thiazolopyridine derivatives of diflapolin as dual sEH\/FLAP inhibitors with improved solubility","volume":"139","author":"Schoenthaler","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib85","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1021\/jm401557w","article-title":"Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo","volume":"56","author":"Hanke","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib86","article-title":"Tryptophan stress activates EGFR\u2013RAS-signaling to MTORC1 and p38\/MAPK to sustain translation and AHR-dependent autophagy","author":"Pf\u00e4nder","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2026.06.056_bib87","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41467-022-30374-9","article-title":"PI(18:1\/18:1) is a SCD1-derived lipokine that limits stress signaling","volume":"13","author":"Th\u00fcrmer","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.056_bib88","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302070120","article-title":"Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution","volume":"120","author":"Rao","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.06.056_bib89","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2009.02.023","article-title":"MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregation","volume":"608","author":"Koeberle","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib90","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1016\/j.ejmech.2011.08.009","article-title":"Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils","volume":"46","author":"Caliskan","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib91","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/acs.jcim.5b00592","article-title":"Discovery of potent soluble epoxide hydrolase (sEH) inhibitors by pharmacophore-based virtual screening","volume":"56","author":"Waltenberger","year":"2016","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2026.06.056_bib92","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cell.2015.05.051","article-title":"A conserved circular network of coregulated lipids modulates innate immune responses","volume":"162","author":"Koberlin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.056_bib93","doi-asserted-by":"crossref","first-page":"D463","DOI":"10.1093\/nar\/gkv1042","article-title":"Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools","volume":"44","author":"Sud","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib94","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.freeradbiomed.2010.07.024","article-title":"Proapoptotic effects of long-chain vitamin E metabolites in HepG2 cells are mediated by oxidative stress","volume":"49","author":"Birringer","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100694","article-title":"Deducing formation routes of oxylipins by quantitative multiple heart-cutting achiral-chiral 2D-LC\u2013MS","volume":"65","author":"Kampschulte","year":"2024","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib96","series-title":"The impact of food bioactives on health: in vitro and ex vivo models","first-page":"161","article-title":"Peripheral blood mononuclear cells","author":"Kleiveland","year":"2015"},{"key":"10.1016\/j.apsb.2026.06.056_bib97","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI42545","article-title":"Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation","volume":"121","author":"Oh","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.056_bib98","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.4049\/jimmunol.1103652","article-title":"Resolvin E2 formation and impact in inflammation resolution","volume":"188","author":"Oh","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.06.056_bib99","doi-asserted-by":"crossref","first-page":"15888","DOI":"10.1096\/fj.201903025RR","article-title":"D-series resolvins activate phospholipase D in phagocytes during inflammation and resolution","volume":"34","author":"Ganesan","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.06.056_bib100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407130121","article-title":"SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor","volume":"121","author":"Alnouri","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.06.056_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2025.106998","article-title":"Phagocytosis is differentially regulated by LPS in M1- and M2-like macrophages via PGE2 formation and EP4 signaling","volume":"178","author":"Kirchhoff","year":"2025","journal-title":"Prostag Other Lipid Mediat"},{"key":"10.1016\/j.apsb.2026.06.056_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2015.07.073","article-title":"Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15)","volume":"573","author":"Ivanov","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.apsb.2026.06.056_bib103","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.chembiol.2011.06.008","article-title":"Novel proresolving aspirin-triggered DHA pathway","volume":"18","author":"Serhan","year":"2011","journal-title":"Chem Biol"},{"key":"10.1016\/j.apsb.2026.06.056_bib104","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41589-020-0544-7","article-title":"Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products","volume":"16","author":"Gilbert","year":"2020","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2026.06.056_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114759","article-title":"Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: the battle between pro- and anti-inflammatory lipid mediators","volume":"193","author":"Gilbert","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib106","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.1016\/S0021-9258(17)36820-5","article-title":"Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin","volume":"269","author":"Lecomte","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib107","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","article-title":"Acetylation of prostaglandin synthase by aspirin","volume":"72","author":"Roth","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.06.056_bib108","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bcp.2008.07.009","article-title":"Celecoxib inhibits 5-lipoxygenase","volume":"76","author":"Maier","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115210","article-title":"Formation of eicosanoids and other oxylipins in human macrophages","volume":"204","author":"Radmark","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib110","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.06.056_bib111","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0076-6879(09)05417-2","article-title":"Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation","volume":"461","author":"Cash","year":"2009","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.apsb.2026.06.056_bib112","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal route of drug administration: should it be used in experimental animal studies?.","volume":"37","author":"Al Shoyaib","year":"2019","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib113","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.freeradbiomed.2016.03.018","article-title":"Vitamin E metabolite 13\u2032-carboxychromanols inhibit pro-inflammatory enzymes, induce apoptosis and autophagy in human cancer cells by modulating sphingolipids and suppress colon tumor development in mice","volume":"95","author":"Jang","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101166","article-title":"The vitamin E derivative garcinoic acid from Garcinia kola nut seeds attenuates the inflammatory response","volume":"24","author":"Wallert","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2026.06.056_bib115","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.06.056_bib116","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib117","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrd.2018.155","article-title":"Corrigendum: new approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Marzo","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.06.056_bib118","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bph.14587","article-title":"Lipid mediators in immune regulation and resolution","volume":"176","author":"Gilroy","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib119","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.06.056_bib120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function","volume":"43","author":"Spector","year":"2004","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib121","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.apsb.2026.06.056_bib122","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.06.056_bib123","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.056_bib124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2026.06.056_bib125","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210518","article-title":"Ferroptosis in infection, inflammation, and immunity","volume":"218","author":"Chen","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2026.06.056_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-688-7_1","article-title":"General review on in vitro hepatocyte models and their applications","volume":"640","author":"Guguen-Guillouzo","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2026.06.056_bib128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-pharmtox-051921-084536","article-title":"Pharmacology of intestinal inflammation and repair","volume":"65","author":"Deraison","year":"2025","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.056_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108753","article-title":"Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation","volume":"265","author":"Peh","year":"2025","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib130","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1038\/s41467-023-41766-w","article-title":"Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples","volume":"14","author":"O\u2019Donnell","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.056_bib131","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1038\/s41467-023-41767-9","article-title":"Reply to: failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples","volume":"14","author":"Dalli","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.056_bib132","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.056_bib133","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","article-title":"Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness","volume":"178","author":"Levy","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.06.056_bib134","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1111\/bph.15156","article-title":"Pro-resolving mediator protectin D1 promotes epimorphic regeneration by controlling immune cell function in vertebrates","volume":"177","author":"Nguyen-Chi","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib135","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1111\/jcmm.16011","article-title":"Protectin DX promotes epithelial injury repair and inhibits fibroproliferation partly via ALX\/PI3K signalling pathway","volume":"24","author":"Yang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib136","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fphar.2018.01582","article-title":"The protectin family of specialized pro-resolving mediators: potent immunoresolvents enabling innovative approaches to target obesity and diabetes","volume":"9","author":"Hansen","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib137","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2147\/JIR.S391765","article-title":"Protectin DX relieve hyperoxia-induced lung injury by protecting pulmonary endothelial glycocalyx","volume":"16","author":"Liang","year":"2023","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib138","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s41598-017-01603-9","article-title":"Protectin DX ameliorates palmitate- or high-fat diet-induced insulin resistance and inflammation through an AMPK\u2013PPARalpha-dependent pathway in mice","volume":"7","author":"Jung","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.056_bib139","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2016.09.017","article-title":"Vitamin E: emerging aspects and new directions","volume":"102","author":"Galli","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib140","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2026.06.056_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1219160","article-title":"Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators","volume":"14","author":"Dahlke","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.056_bib142","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.biotechadv.2018.02.010","article-title":"Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis","volume":"36","author":"Koeberle","year":"2018","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.apsb.2026.06.056_bib143","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.056_bib144","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s42255-022-00600-1","article-title":"Metabolic messengers: endocannabinoids","volume":"4","author":"Busquets-Garcia","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2026.06.056_bib145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev-pharmtox-010818-021441","article-title":"Beyond THC and endocannabinoids","volume":"60","author":"Pacher","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.056_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107495","article-title":"Cannabinoids in the descending pain modulatory circuit: role in inflammation","volume":"209","author":"Bouchet","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib147","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2026.06.056_bib148","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00000542-200310000-00031","article-title":"Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors","volume":"99","author":"Quartilho","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.apsb.2026.06.056_bib149","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvp240","article-title":"CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages","volume":"84","author":"Han","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","article-title":"Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases","volume":"180","author":"Wagner","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.056_bib151","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1194\/jlr.D700001-JLR200","article-title":"Identification and quantitation of novel vitamin E metabolites, sulfated long-chain carboxychromanols, in human A549 cells and in rats","volume":"48","author":"Jiang","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib152","first-page":"1","article-title":"Garcinia kola: a critical review on chemistry and pharmacology of an important West African medicinal plant","author":"Tauchen","year":"2023","journal-title":"Phytochem Rev"},{"key":"10.1016\/j.apsb.2026.06.056_bib153","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0968-0896(01)00428-X","article-title":"Powerful antioxidative agents based on garcinoic acid from Garcinia kola","volume":"10","author":"Terashima","year":"2002","journal-title":"Bioorg Med Chem"},{"issue":"Suppl 1","key":"10.1016\/j.apsb.2026.06.056_bib154","article-title":"Regulation of inflammatory pathways by an a-tocopherol long-chain metabolite and a d-tocotrienol-related natural compound","volume":"75","author":"Schmolz","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.06.056_bib155","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1002\/ptr.7315","article-title":"Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-kappaB activation","volume":"35","author":"Olajide","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.apsb.2026.06.056_bib156","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1021\/acs.jmedchem.0c00012","article-title":"Garcinoic acid is a natural and selective agonist of pregnane X receptor","volume":"63","author":"Bartolini","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib157","doi-asserted-by":"crossref","first-page":"14802","DOI":"10.1021\/jacs.3c03417","article-title":"Targeting the alternative vitamin E metabolite binding site enables noncanonical PPARgamma modulation","volume":"145","author":"Arifi","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2026.06.056_bib158","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1007\/s10753-025-02269-6","article-title":"The vitamin E derivative garcinoic acid suppresses NLRP3 inflammasome activation and pyroptosis in murine macrophages","volume":"48","author":"Bormel","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.apsb.2026.06.056_bib159","doi-asserted-by":"crossref","first-page":"11866","DOI":"10.1074\/jbc.RA120.013303","article-title":"Garcinoic acid prevents beta-amyloid (Abeta) deposition in the mouse brain","volume":"295","author":"Marinelli","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.06.056_bib160","article-title":"Reorganization of innate immune cell lipid profiles by bioinspired meroterpenoids to limit inflammation","author":"Waltl","year":"2024","journal-title":"bioRxiv"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:17:23Z","timestamp":1789600643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526004181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":160,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211383526004181"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.056","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tocotrienol metabolites redirect lipid mediator production in innate immune cells towards inflammation resolution","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}